| Endometrial Carcinoma studied in …STUDIED_INderived200 of 325show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07198074Phase 3 · recruiting Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643510Phase 2 · completed Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838207recruiting Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791635active not recruiting Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812636early Phase 1 · not yet recruiting Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00977574Phase 2 · active not recruiting Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367741Phase 2 · active not recruiting Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02257528Phase 2 · active not recruiting Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01366144Phase 1 · active not recruiting Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02208375Phase 1 · active not recruiting mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704661Phase 1 · active not recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139368NA · active not recruiting Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950464Phase 1 · recruiting Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216105Phase 1 · recruiting FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04839614NA · recruiting Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662824NA · recruiting Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349641Phase 2 · not yet recruiting A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781150Phase 2 · not yet recruiting Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466971Phase 3 · active not recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548296Phase 2 · recruiting A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04567771NA · recruiting Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05827614Phase 1 · terminated Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | High Grade Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919264Phase 1/Phase 2 · recruiting FOG-001 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05231122Phase 2 · recruiting Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06543576Phase 1/Phase 2 · recruiting External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05046080recruiting Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07741968NA · recruiting A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038369Phase 1 · active not recruiting A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07281547Phase 4 · not yet recruiting Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05554328Phase 2 · active not recruiting Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05603910Phase 1 · recruiting Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595879Phase 1 · active not recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07738315Phase 2 · not yet recruiting Elemene Liposomes in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285044Phase 2 · recruiting The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538897Phase 1/Phase 2 · active not recruiting Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586661Phase 1 · completed Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07723235NA · not yet recruiting Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04092270Phase 1 · active not recruiting A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial High Grade Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06476808Phase 1 · recruiting A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07715747Phase 1 · not yet recruiting A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469764Phase 2 · recruiting Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05078047Phase 3 · active not recruiting Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04622670NA · active not recruiting Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092373Phase 1 · recruiting Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129604Phase 2 · active not recruiting Pilot Window of Opportunity Trial (POET) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07527143recruiting Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214067Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07436793Phase 2 · recruiting Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675733NA · not yet recruiting A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691010early Phase 1 · recruiting A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06213571NA · completed Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Transitional Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967961NA · recruiting Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251416Phase 2 · active not recruiting A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04494113early Phase 1 · active not recruiting Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06365905recruiting Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07634601Phase 2 · not yet recruiting Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107334Phase 2 · recruiting A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316467Phase 2/Phase 3 · terminated Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03671811Phase 2 · active not recruiting Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05523440Phase 2 · terminated Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730347Phase 2 · recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454642Phase 1 · recruiting AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039801Phase 1 · recruiting IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008408Phase 2 · active not recruiting A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102252NA · completed Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634617active not recruiting Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07583329not yet recruiting Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691504Phase 1 · active not recruiting Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04713618active not recruiting Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790004active not recruiting Endometrial Carcinoma: Comparison of Surgical Approaches (Laparoscopy vs Laparotomy) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05049538recruiting Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737619NA · active not recruiting PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146919Phase 1/Phase 2 · withdrawn AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02874430Phase 2 · terminated Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04678414active not recruiting Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07062016recruiting Molecular and ctDNA Characterization of High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253494Phase 1/Phase 2 · recruiting Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05036681Phase 2 · terminated A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870761Phase 2 · active not recruiting Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276360Phase 2 · recruiting Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04814108Phase 2 · completed A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06349642recruiting Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03968406Phase 1 · recruiting Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05824481Phase 2 · active not recruiting Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06369155Phase 2 · recruiting Azenosertib in Uterine Serous Carcinoma: Biomarker Study · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06689956recruiting Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07407959recruiting Screening and Staging of Benign vs Malignant Pelvic Abnormalities · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781088Phase 2 · active not recruiting Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226102NA · withdrawn Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07374809NA · not yet recruiting IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576104Phase 2 · active not recruiting Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06518564Phase 2 · recruiting Avelumab and M1774 in ARID1A-mutated Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07316361early Phase 1 · enrolling by invitation GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855706NA · recruiting An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03027479NA · completed Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05407025active not recruiting Targeting Inflammation for Endometrial Cancer Prevention · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422198Phase 3 · recruiting Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07267780not yet recruiting Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases. · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07070518Phase 1/Phase 2 · recruiting Study of GV20-0251 in Participants With Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05997017Phase 2 · recruiting Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03738228Phase 1 · completed Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902988Phase 1/Phase 2 · recruiting A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04574635active not recruiting Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03325634Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049227early Phase 1 · completed Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106414Phase 2 · active not recruiting Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03460483NA · completed Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06861855not yet recruiting Prognosis of METTL-14 in Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06264921Phase 1 · terminated A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628067Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153952Phase 1/Phase 2 · active not recruiting RT for Adenocarcinoma/Adenosquamous Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03300557Phase 2 · completed Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04080284Phase 2 · completed Trial of Maintenance With Niraparib- Uterine Serous Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04159155Phase 2/Phase 3 · terminated A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491643Phase 2 · completed Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07077876recruiting Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611024Phase 1/Phase 2 · completed Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028242not yet recruiting Ultrasound and Histology in AEH and Early EEC Treated Conservatively · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07015593not yet recruiting Patient Journey in Advanced Gynecologic Cancers · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101451Phase 3 · completed Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03508570Phase 1 · completed Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647109recruiting Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983279NA · completed Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917092Phase 2 · recruiting QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06502743Phase 2 · recruiting First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05192850withdrawn Endometrial Cancer Recurrence in Patients Taking Metformin · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06893861recruiting Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684227Phase 2 · completed Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03552471Phase 1 · completed Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04906382early Phase 1 · terminated Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669430Phase 1/Phase 2 · recruiting A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06677242not yet recruiting Serous Endometrial Intraepithelial Carcinoma (SEIC): Prospective Registration Study · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Serous Endometrial Intraepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805864Phase 2 · not yet recruiting Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06789224NA · completed Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02630823Phase 1 · completed MK-3475 Immunotherapy in Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03241745Phase 2 · completed A Study of Nivolumab in Selected Uterine Cancer Patients · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655260NA · recruiting PErsonalized TReatment for Endometrial Carcinoma · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03745950Phase 2 · completed UTOLA: UTerin OLAparib · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06278857Phase 2 · recruiting SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr) · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06632431recruiting Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04652076Phase 1/Phase 2 · active not recruiting GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03677024NA · withdrawn Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01686126Phase 2 · active not recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01344837completed Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001282Phase 1/Phase 2 · terminated A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521684unknown Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Microsatellite Stable Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02501954Phase 3 · completed Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04257045completed Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675787Phase 2 · unknown Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03752398Phase 1 · completed A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164461Phase 1 · completed Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06413992Phase 2 · recruiting Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972682NA · completed [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01649089NA · unknown Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Cervical Adenosquamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390021NA · withdrawn PET/MRI in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02730923Phase 1/Phase 2 · unknown Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03015129Phase 2 · completed A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06066216Phase 2 · not yet recruiting Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04716686Phase 2 · recruiting Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367923Phase 2 · completed Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04474184Phase 1 · completed Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584478Phase 3 · unknown Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05712941Phase 3 · withdrawn Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041027Phase 2 · terminated Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05498597Phase 1 · unknown AMT-151 in Patients With Selected Advanced Solid Tumours · condition mapped CURATED_BROADER · 325 trials mapped (139 active) | — | — | Endometrial Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465541NA · completed Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112552Phase 2 · terminated Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer · condition mapped ONTOLOGY_EXACT · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590248Phase 2 · completed A Study of Adavosertib as Treatment for Uterine Serous Carcinoma · condition mapped ALIAS · 325 trials mapped (139 active) | — | — | Endometrial Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |